193 related articles for article (PubMed ID: 33242831)
1. Estrogen-induced hypomethylation and overexpression of YAP1 facilitate breast cancer cell growth and survival.
Muhammad JS; Guimei M; Jayakumar MN; Shafarin J; Janeeh AS; AbuJabal R; Eladl MA; Ranade AV; Ali A; Hamad M
Neoplasia; 2021 Jan; 23(1):68-79. PubMed ID: 33242831
[TBL] [Abstract][Full Text] [Related]
2. YAP1 overexpression is associated with poor prognosis of breast cancer patients and induces breast cancer cell growth by inhibiting PTEN.
Guo L; Chen Y; Luo J; Zheng J; Shao G
FEBS Open Bio; 2019 Mar; 9(3):437-445. PubMed ID: 30868052
[TBL] [Abstract][Full Text] [Related]
3. Eliminating epigenetic barriers induces transient hormone-regulated gene expression in estrogen receptor negative breast cancer cells.
Fleury L; Gerus M; Lavigne AC; Richard-Foy H; Bystricky K
Oncogene; 2008 Jul; 27(29):4075-85. PubMed ID: 18317449
[TBL] [Abstract][Full Text] [Related]
4. Global identification of genes regulated by estrogen signaling and demethylation in MCF-7 breast cancer cells.
Putnik M; Zhao C; Gustafsson JÅ; Dahlman-Wright K
Biochem Biophys Res Commun; 2012 Sep; 426(1):26-32. PubMed ID: 22902638
[TBL] [Abstract][Full Text] [Related]
5. miR-191/DAB2 axis regulates the tumorigenicity of estrogen receptor-positive breast cancer.
Tian X; Zhang Z
IUBMB Life; 2018 Jan; 70(1):71-80. PubMed ID: 29247596
[TBL] [Abstract][Full Text] [Related]
6. LncRNA HOTAIR promotes the migration and invasion of cervical cancer through DNMT3B/LATS1/ YAP1 pS127 axis.
Zhang Z; Zhou X; Li J; Meng Q; Zheng P
Reprod Biol; 2024 Jun; 24(2):100893. PubMed ID: 38754347
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
[TBL] [Abstract][Full Text] [Related]
8. Physalin A, 13,14-Seco-16, 24-Cyclo-Steroid, Inhibits Stemness of Breast Cancer Cells by Regulation of Hedgehog Signaling Pathway and Yes-Associated Protein 1 (YAP1).
Ko YC; Choi HS; Liu R; Lee DS
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445421
[TBL] [Abstract][Full Text] [Related]
9. Estrogen down regulates COMT transcription via promoter DNA methylation in human breast cancer cells.
Wu Q; Odwin-Dacosta S; Cao S; Yager JD; Tang WY
Toxicol Appl Pharmacol; 2019 Mar; 367():12-22. PubMed ID: 30684530
[TBL] [Abstract][Full Text] [Related]
10. Nuclear-encoded mitochondrial MTO1 and MRPL41 are regulated in an opposite epigenetic mode based on estrogen receptor status in breast cancer.
Kim TW; Kim B; Kim JH; Kang S; Park SB; Jeong G; Kang HS; Kim SJ
BMC Cancer; 2013 Oct; 13():502. PubMed ID: 24160266
[TBL] [Abstract][Full Text] [Related]
11. CpG island shore methylation regulates caveolin-1 expression in breast cancer.
Rao X; Evans J; Chae H; Pilrose J; Kim S; Yan P; Huang RL; Lai HC; Lin H; Liu Y; Miller D; Rhee JK; Huang YW; Gu F; Gray JW; Huang TM; Nephew KP
Oncogene; 2013 Sep; 32(38):4519-28. PubMed ID: 23128390
[TBL] [Abstract][Full Text] [Related]
12. RSK4 inhibits breast cancer cell proliferation and invasion in vitro, and is correlated with estrogen receptor upregulation in breast cancer.
Huo H; Ye X; Yang H; Li Q; Jiang Y
Oncol Rep; 2019 Dec; 42(6):2777-2787. PubMed ID: 31545499
[TBL] [Abstract][Full Text] [Related]
13. RUNX3 Epigenetic Inactivation Is Associated With Estrogen Receptor Positive Breast Cancer.
Liu H; Yan Z; Yin Q; Cao K; Wei Y; Rodriguez-Canales J; Ma D; Wu Y
J Histochem Cytochem; 2018 Oct; 66(10):709-721. PubMed ID: 30133331
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor α attenuates therapeutic efficacy of paclitaxel on breast xenograft tumors.
Chang J; Sui M; Fan W
Breast Cancer Res Treat; 2012 Aug; 134(3):969-80. PubMed ID: 22374518
[TBL] [Abstract][Full Text] [Related]
15. ERα propelled aberrant global DNA hypermethylation by activating the DNMT1 gene to enhance anticancer drug resistance in human breast cancer cells.
Si X; Liu Y; Lv J; Ding H; Zhang XA; Shao L; Yang N; Cheng H; Sun L; Zhu D; Yang Y; Li A; Han X; Sun Y
Oncotarget; 2016 Apr; 7(15):20966-80. PubMed ID: 26980709
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation of estrogen signaling in breast cancer.
Hervouet E; Cartron PF; Jouvenot M; Delage-Mourroux R
Epigenetics; 2013 Mar; 8(3):237-45. PubMed ID: 23364277
[TBL] [Abstract][Full Text] [Related]
17. Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer.
Lu W; Katzenellenbogen BS
Horm Cancer; 2017 Aug; 8(4):230-242. PubMed ID: 28577282
[TBL] [Abstract][Full Text] [Related]
18. Antibody-drug conjugate T-DM1 treatment for HER2+ breast cancer induces ROR1 and confers resistance through activation of Hippo transcriptional coactivator YAP1.
Islam SS; Uddin M; Noman ASM; Akter H; Dity NJ; Basiruzzman M; Uddin F; Ahsan J; Annoor S; Alaiya AA; Al-Alwan M; Yeger H; Farhat WA
EBioMedicine; 2019 May; 43():211-224. PubMed ID: 31085100
[TBL] [Abstract][Full Text] [Related]
19. Anti-proliferative effect of estrogen in breast cancer cells that re-express ERalpha is mediated by aberrant regulation of cell cycle genes.
Moggs JG; Murphy TC; Lim FL; Moore DJ; Stuckey R; Antrobus K; Kimber I; Orphanides G
J Mol Endocrinol; 2005 Apr; 34(2):535-51. PubMed ID: 15821115
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer.
Simigdala N; Gao Q; Pancholi S; Roberg-Larsen H; Zvelebil M; Ribas R; Folkerd E; Thompson A; Bhamra A; Dowsett M; Martin LA
Breast Cancer Res; 2016 Jun; 18(1):58. PubMed ID: 27246191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]